IRF7 and neoplasm: In fact, it has been emphasized that the strengthening of tumour cells immunogenicity, by enhancing the Irf7 axis within own cancerous cells, can significantly enhance the effectiveness of WTCVs and make them a potent option for preventing tumour recurrence (143).